Inflammatory mediators- Pharmacology

680 views 28 slides Jun 15, 2021
Slide 1
Slide 1 of 28
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28

About This Presentation

Definition: Any messenger that acts on blood vessels, inflammatory cells, or other cells to contribute to an inflammatory response.
Cell derived mediators


Plasma derived mediators
vasoactive amines (serotonin,histamine)
arachidonic acid metabolites
cycloxygenase pathway
lipoxygenase pathway
Lys...


Slide Content

INFLLAMATORY MEDIATORS BY;- SANCHIT DHANKHAR 1

Mediators of inflammation Definition: Any messenger that acts on blood vessels, inflammatory cells, or other cells to contribute to an inflammatory response. 2 2

Classification 3 3 Cell derived mediators Plasma derived mediators

4 4

1. Cell derived mediators 5 5 v asoac t i v e ami n es ( se r o t o n i n ,his t a m i n e) arachidonic acid metabolites c y cl o x yg enase pat h w a y lipoxygenase pathway Lysosomal components P la t elet act i v ating fac t or Cytokines ( IL-1,TNF-α,TNF-β,IF-γ,Chemokines) f) Nitric oxide and oxygen metabolites

a) Vasoactive amines 6 Histamine :- Stored in granuls of mast cells, basophiles and platelets. Released by the stimuli of various agents like Heat, Cold, Irradiation, Irritant chemicals, Anaphilatoxins, Interleukins,.. etc. Actions ; Vasodilation V ascular permeab i lity Itching and pain 6

Serotonin/5-hydroxy tryptamine :- Present in chromafin cells of GIT, Spleen, Nervous tissue, Mast cells, Platelets. Actions ; Similar to Histamine, but less potent Vasodilation V ascular p e rmeab i lity 7 7

b) Arachidonic acid Metabolites Lipoxygenase pathway Cyclo-oxygenase pathway 8 8

Cell membrane phospholipids 9 Stimulus (phospholipase) (Inhibition by st ero i ds) Arachidonic Chemotactic lipids O 2 - 5 Li p oxi g ena s e ac i d O 2 O 2 Cyclooxigenase (inhibitable w/ aspirin, indomethacin) 5HPE T E LTA 4 LTC 4 LT D 4 LTE 4 5 HE T E Chemotaxis LTB 4 Chemotaxis Vasoconstriction Bronchoconstricti o n ↑Vascular permeability 2 2 x PG G PG H + [O ] pero x idase sin t e t as e sin t e t as e Inhibits Pro st a cyclin PGI2 thrombocyte aggr. Vasodilatation Enhances oedema formation Thro m bo x ane A 2 Vasoconstrictio n Isomerase Thro m bocyte aggregation Reductase PG E PGD 2 PGF2 α Vasodilatation Oedema formation Che mot a ctic lipids

c) Lysosomal comonents 10 10 Sou r c e : - N eu t r o p hiles and mon o c y t es Potent mediators Degredation of bacterial and extracellular components Chemotaxis Realease of acid proteases, collagenase, elastase, plasminogen activator

d) Platelet activating factor 11 Phospholipid derived mediator Released from :- Platelets, basophil, mast cells, neutrophils macrophages, endothelial cells Actions :- V ascular p e rmeab i lity Vasoconstriction Vasodilatation Bronchoconstriction Adhesion of leukocytes to endothelium Chemotaxis, degranulation

e) Cytokines 12 “Cytokines are a diverse group of small protein molecules with potent biological activity whose main function is in the regulation of immune responses.” Main Cytokines are :- Interleukins Interferons T u m or nec r os i s fac t or Chemokines Transforming growth factor-beta Adipokines- leptin & adiponectin

Actions :- Adhesion of leucocytes to endothelium Synthesis of Prostacyclin, which is a vasodilator and anti agg r ega t or of pl a t elets S y n the s i s of P A F and th r ombo g enic ef f ect on endothelial surface 13

f) Nitric oxide and oxygen metabolites 14 Endothelium derived relaxing factor Macrophages, endothelial cells, neurons Actions :- Vasodilation Anti-platelet activating agent Microbicidal action H 2 O 2 , Superoxide, Toxic NO products produced by activated neutrophiles and microphages Actions :- E n d o th elial c ell dam a g e, t i ssue dam a g e and v ascular permeability

2.Plasma derived mediators 15 The kinin system The clotting system The fibrinolytic system Th e c om p lement s y s t em

4 interlinked systems H a g eman fac t or( f ac t or X II) End product of clotting ,fibrinolytic ,kinin system will act i v a t e c omplement s y s t em. 16

a) The kinin system 17 fac t or X II c o n tact fac t or X I I a prekallikrein activator Plasma prekallikrein kalli k r ein ki n i n o g en bradykinin

Actions :- Smooth m u scle c o n t r action Vasodilation v ascular permeab i lity pain 18

b) Clotting system 19 fac t or XII c o n tact factor XIIa XI XIa +VIIa +PF3 X X a + V a + P F3 prothrombin thrombin f ibr i n o f ibr i n o g en f ibr i n Peptides plasmin

Actions :- Inc r ease v ascular permeab i lity Chemotaxis for leucocytes Anti c oa g ulan t act i vity 20

C) Fibrinolytic system 21

Actions :- Activation of factor XII to form prekallikrein activator that stimulates kinin system to generate bradykinin Spl i t s o f f c om p lement c 3 t o f o r m c3a, w hich is permeability factor Degrades fibrin to split products, they increase v ascular permeab i lity 22

D) Complement system 23 P r oduct of c omplement s y s t em i s ana p h y la t o xi n s c3a and c5a. Potency is c3a>c5a>c4a A ctio n s : - r elease histamine f r om mas t c ells and basophils C5a is chemotactic for leucocytes. Membrane attack complex cause pores in cell of invading microbes.

Inflammatory mediators and their function I. 24 Mediators Function Histamine, serotonin, bradykinin, C3a, C5a, PGD 2 , PGE 2 , PGI2, LTC 4 , active Hageman factor, fibrinopeptids Increase the permeability of small vessel FMLP, C5a, TXA 2 , LTB 4 , LTC 4 , LTD 4 , LTE 4 Vasoconstriction Hisztamin, szerotonin, bradykinin, C3a, C5a, TXA 2 , LTB 4 , LTC 4 , LTD 4 , LTE 4 , PAF Smooth muscle contraction C3a, C5a, MCP-1, IL-8 Degranulation of mast and basophil cells LPS, LTD 4 , IL-1, TNF-α, MCP-1 Increased endothel cell cohesion Bradykinin, PGE 2 Pain IL-1, IL-6, TNF-α, MIP-1, PGE 2 Pirogenes TXA 2 , PAF Thrombocyte aggregation

Mediators Function FMLP, C5a, IL-8 and other chemokins, LTB 4, PAF, laminin, kollagene fragments, fibrinopeptids, C3b, iC3b, IgG (Fc rész), fibronectin, C 5 a, P A F , TN F - α , I L -8, most chemoattractant, phagocytic materials -phagocytes -chemotaxis -cohesion and phagocytosis -reactive, intermedier O 2 formation and release of lysosomal granules Serum am y loid A (SA A ), C R P , fibrinogene, α 1 -antitripsin, haptoglobin, ceruloplasmin, stb. Acute phase proteins TNF-α, TNF-β, PAF, reactive O 2 intermediers (ROI), reactive N 2 intermediers (RNI), lysosomal enzymes Possible injury of mast cells and tissues bFGF, GM-CSF, TGF- β, TGF- α, IGF-1, PDGF, VEGF/VPF, IL-1, IL-6, IL-8, TNF-α, interferons Angiogenezis Inflammatory mediators and their function II. 25

- C-1 inhibitor -  -2 macroglobulin - Antithrombin - III -  -1 protease inhibitor 26

27

THANKYOU 28